Hesitancy Prevalence and Sociocognitive Barriers to Coronavirus Vaccinations in Nigeria

Oguntayo, Rotimi; Olaseni, Abayomi O.; Ogundipe, Abiodun

doi:10.2478/eras-2021-0008

Cited by 2 publications

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Acceptance and hesitancy of COVID-19 vaccine among university community members of Otukpo, Nigeria: a cross-sectional study

Zakari,

Ogbu,

Zakari

et al. 2023

Discov glob soc

View full text Add to dashboard Cite

Coronavirus disease (COVID-19) is a global public health problem that has had a detrimental influence on the economy of countries of the world, including Nigeria: (1) Background: The study aimed to assess COVID-19 vaccine acceptance and hesitancy among staff and students at Federal University of Health Sciences Otukpo, Benue State, Nigeria, while exploring the factors influencing these attitudes; (2) Methods: A web-based cross-sectional survey was conducted between November 2021 and April 2022, with data analyzed using descriptive and inferential statistics; (3) Results: Of the hundred and fifty (150) completed and analysed questionnaires the mean age of the respondents was 34.8 ± 8.64 years, of which majority of them 80.0% (122) ranging between 16 and 45 years. The majority of the respondents 77.3% (116) have been tested for the virus to know their status. In total, 51.2% of trial participants indicated hesitancy to get the COVID-19 vaccine. The two most frequent reasons for hesitation were scepticism about the vaccination due to fast production and rollout (32.2%) and fear of vaccine side effects due to social media movements (23.3%). The most often cited reasons for not receiving the COVID-19 vaccination included uncertainty about its efficacy, a lack of knowledge about the vaccine, a preference for another kind of protection, and unreliability of the vaccine (due to its rapid development). Staff category (Academics, non-academics, students, and health workers), age, and religion were the significant associated factors influencing vaccine acceptance and hesitancy (P < 0.05); (4) Conclusions: The university community has a high level of awareness of COVID-19 pandemic but vaccine acceptance is low resulting high levels of vaccine hesitancy. These findings suggest that there is a need for further information and education on the COVID-19 vaccine, particularly in communities where vaccine hesitancy is prevalent. This can be achieved through targeted outreach programs, community engagement initiatives, and effective communication strategies that address the concerns and questions of individuals who are hesitant about receiving the vaccine.

show abstract

Acceptance and hesitancy of COVID-19 vaccine among university community members of Otukpo, Nigeria: a cross-sectional study

Zakari,

Ogbu,

Zakari

et al. 2023

Discov glob soc

View full text Add to dashboard Cite

show abstract

COVID-19 Vaccine Acceptance in Nigeria: A Rapid Systematic Review and Meta-Analysis

Nnaemeka

Okafor

Orababa

et al. 2023

Preprint

View full text Add to dashboard Cite

Widespread COVID–19 vaccination is essential to maintaining pandemic control. However, low–and lower–middle–income countries (LMICs) continue to face challenges to care due to unequal access and vaccine fear despite the introduction of safe and effective immunisations. This study aimed to collect information on Nigeria's COVID–19 vaccine uptake rates and determinants. Science Direct, PubMed, Google Scholar, African Journal Online, Springer, and Hinari were all systematically searched through and completed in May 2022. Quality assessments of the listed studies were performed using the eight–item Joanna Briggs Institute Critical Appraisal tools for cross–sectional studies. In addition, we undertook a meta-analysis to calculate pooled acceptance rates with 95% confidence intervals (CI). Forty–two studies in total satisfied the inclusion criteria and were reviewed. A total of 24,533 respondents were studied. The total sample size of states in the Northern, Western and Southern parts of Nigeria are 3,206, 4,527 and 5,059, respectively, while 11,741 is the cumulative sample size of all the Nigeria-wide studies. The total COVID–19 vaccination acceptance rate among all the study groups was 52.4% (95% CI: 46.9–57.9%, I2 = 100%), while the total estimated COVID–19 vaccination hesitancy rates was 47.81% (95% CI: 42.2 – 53.4% I2 = 100%). In Nigeria–regions sub–group analyses, the Western region (58.90%, 95% CI: 47.12–70.27%) and Northern region (54.9%, 95% CI: 40.11%–69.4%) showed the highest rates of vaccine acceptance and vaccine hesitancy respectively. The COVID–19 vaccine acceptance rate was highest in 2020, with a pooled rate of 59.56% (46.34, 57.32%, I2 = 98.7%). The acceptance rate in 2021 was only 48.48 (40.78%, 56.22%), while for the studies in 2022, it increased to 52.04% (95% CI: 35.7%, 68.15 %). The sensitisation of local authorities and the dissemination of more detailed information about the COVID–19 vaccine and its safety, could significantly increase the country's vaccination rate.

show abstract

Hesitancy Prevalence and Sociocognitive Barriers to Coronavirus Vaccinations in Nigeria

Cited by 2 publications

References 20 publications

Acceptance and hesitancy of COVID-19 vaccine among university community members of Otukpo, Nigeria: a cross-sectional study

Acceptance and hesitancy of COVID-19 vaccine among university community members of Otukpo, Nigeria: a cross-sectional study

COVID-19 Vaccine Acceptance in Nigeria: A Rapid Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About